Baek Moo-Jin, Park Hyun-Min, Johnson Justin M, Altuntas Cengiz Z, Jane-Wit Daniel, Jaini Ritika, Solares C Arturo, Thomas Dawn M, Ball Edward J, Robertson Nahid G, Morton Cynthia C, Hughes Gordon B, Tuohy Vincent K
Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
J Immunol. 2006 Sep 15;177(6):4203-10. doi: 10.4049/jimmunol.177.6.4203.
Autoimmune sensorineural hearing loss (ASNHL) is the most common cause of sudden hearing loss in adults. Although autoimmune etiopathogenic events have long been suspected in ASNHL, inner ear-specific Ags capable of targeting T cell autoreactivity have not been identified in ASNHL. In this study, we show by ELISPOT analysis that compared with normal hearing age- and sex-matched control subjects, ASNHL patients have significantly higher frequencies of circulating T cells producing either IFN-gamma (p = 0.0001) or IL-5 (p = 0.03) in response to recombinant human cochlin, the most abundant inner ear protein. In some patients, cochlin responsiveness involved both CD4+ and CD8+ T cells whereas other patients showed cochlin responsiveness confined to CD8+ T cells. ASNHL patients also showed significantly elevated cochlin-specific serum Ab titers compared with both normal hearing age- and sex-matched control subjects and patients with noise- and/or age-related hearing loss (p < 0.05 at all dilutions tested through 1/2048). Our study is the first to show T cell responsiveness to an inner ear-specific protein in ASNHL patients, and implicates cochlin as a prominent target Ag for mediating autoimmune inner ear inflammation and hearing loss.
自身免疫性感音神经性听力损失(ASNHL)是成人突发性听力损失的最常见原因。尽管长期以来一直怀疑ASNHL存在自身免疫性致病事件,但尚未在ASNHL中鉴定出能够靶向T细胞自身反应性的内耳特异性抗原。在本研究中,我们通过ELISPOT分析表明,与听力正常、年龄和性别匹配的对照受试者相比,ASNHL患者对重组人耳蜗蛋白(内耳中最丰富的蛋白质)产生干扰素-γ(p = 0.0001)或白细胞介素-5(p = 0.03)的循环T细胞频率显著更高。在一些患者中,耳蜗蛋白反应性涉及CD4 +和CD8 + T细胞,而其他患者的耳蜗蛋白反应性仅限于CD8 + T细胞。与听力正常、年龄和性别匹配的对照受试者以及患有噪声性和/或年龄相关性听力损失的患者相比,ASNHL患者的耳蜗蛋白特异性血清抗体滴度也显著升高(在所有测试稀释度直至1/2048时p < 0.05)。我们的研究首次表明ASNHL患者的T细胞对一种内耳特异性蛋白有反应,并表明耳蜗蛋白是介导自身免疫性内耳炎症和听力损失的主要靶抗原。